0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Clinical Implications

Session 1: Genetics of migraine

Mikko Kallela

Assistant Professor, Neurology specialist at Helsinki University Central Hospital and Helsinki Headache Center, Finland

Download presentation

Previous

Genetic aspects and latest findings

Next

PACAP and VIP

You Might Also Like

Related Embedded Video Item Thumbnail Genetic aspects and latest findings
Related Embedded Video Item Thumbnail Combination therapy and switching
Related Embedded Video Item Thumbnail Discrepancy between the recommendations and reimbursement regulations of the anti-CGRPs in the Nordics
Related Embedded Video Item Thumbnail Societal burden of migraine
Related Embedded Video Item Thumbnail Targeting ion channels

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128